Fig. 4From: Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in humanChanges in anti-Müllerian hormone (AMH) level during follow-up in all 9 premature ovarian failure (POF) patientsBack to article page